Sanborn EPA 6 ECDWE Environmental Engineer EPA Lead Inspector Signature/Date Supervisor Signature/Date Kent W.

Sanborn EPA 6 ECDWE Environmental Engineer EPA Lead Inspector Signature/Date Supervisor Signature/Date Kent W.

Dallas, Texas 75229 Clay County 940-855-6834 Main Office FRS Number: Identification/Permit Number: Media Identifier Number: NAICS: SIC: N/A TXU011247 N/A 21111 1311 Personnel participating in inspection: Jeanne Eckhart EPA 6 ECDWE Kayla Woods EPA 6 ECDWE Inspector Inspector EPA Lead Inspector Signature/Date Supervisor Signature/Date JEANNE ECKHART Digitally signed by JEANNE ECKHART DN: c=US, o=U.S.

Sanborn EPA 6 ECDWE Environmental Engineer EPA Lead Inspector Signature/Date Supervisor Signature/Date Kent W.

Morgan Road Oklahoma City, Oklahoma, 73128 Osage 918-287-6811 Talia Clark HSE Tech FRS Number: Identification/Permit Number: Media Identifier Number: NAICS: SIC: n/a OKU002129 n/a 211111 1311 Personnel participating in inspection: Matthew Allen EPA/Region 6 ECDW Inspector EPA Lead Inspector Signature/Date Supervisor Signature/Date MATTHEW ALLEN Date: 2023.11.29 08:56:34 -06'00' Digitally signed by MATTHEW ALLEN Matthew Allen Date JEANNE ECKHART Date: 2023.11.29 09:36:19 -06'00' Digitally signed by JEANNE ECKHART Jeanne Eckhart Date 6ENFORM-019-R8.2 (02/12/2020) 1 Section I - INTRODUCTION CapturePoint, LLC / North Burbank Unit 31 Battery Inspection Date 11/14/2023 PURPOSE OF THE INSPECTION EPA Region 6 inspector Matthew Allen arrived at the CapturePoint, LLC / North Burbank Unit (NBU) 31 Battery (EPA ID No.

Rose Malanga, Nick Bruno (Lead) and Mike McFadden participated during the inspection as part of the On the Job Training requirement associated with the SDWA/UIC inspector credentialing process.

FW: <External Messa e> HUD Daily Briefing (2-3-25) From: To: Date: Attachments: "Lee, Jessica K.

NEICVP1465E01 NEIC CIVIL INVESTIGATION REPORT Clean Earth Environmental Solutions, Inc.

As a result, they have been produced in large quantities and used in a variety of industrial, commercial, and consumer applications since the late 1940s.2, 3, 4 The main concern of the lead Member State Competent Authorities (MSCAs) regarding PFAS are their high environment persistence, significantly exceeding the very persistent (vP) threshold set out in Annex XIII of the REACH Regulation.

Dean Ojala, Jr., CT3 Maintenance Mechanic Lead, about the container and he said they puncture aerosols into the contai

SOCIO-ECONOMIC ANALYSIS Of the potential restriction of the perand polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products SUBSTANCES: per- and polyfluoroalkyl substances (PFAS) used for medicinal products FROM: European Federation of Pharmaceutical Industries and Associations (EFPIA) USE: For Human Medicinal Products DATE: 17 August 2023 PREPARED BY: EPPA SA/NV Place du Luxembourg 2 1050 Brussels, Belgium EU Transparency Register: 31367501249-92 SOCIO-ECONOMIC ANALYSIS | PFAS | EU REACH SOCIO-ECONOMIC ANALYSIS Of the potential restriction of the per- and polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products PROJECT TITLE: Socio-economic analysis of the potential restriction of the per- and polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products VERSION: 17 August 2023 PREPARED FOR: European Federation of Pharmaceutical Industries and Associations (EFPIA) PERFORMED BY: EPPA (www.eppa.com) CITATION: EPPA, `Socio-economic analysis of the potential restriction of the per- and polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products', Report for EFPIA, July 2023 DISCLAIMER: The views expressed in this report are, unless otherwise stated, those of the authors and do not necessarily represent any official view of EFPIA and/or any other organization mentioned in this report. 2 CONTENTS SOCIO-ECONOMIC ANALYSIS | PFAS | EU REACH CONTENTS......................................................................................................................... 3 ABBREVIATIONS ................................................................................................................ 5 DEFINITIONS ..................................................................................................................... 7 1.

SOCIO-ECONOMIC ANALYSIS Of the potential restriction of the perand polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products SUBSTANCES: per- and polyfluoroalkyl substances (PFAS) used for medicinal products FROM: European Federation of Pharmaceutical Industries and Associations (EFPIA) USE: For Human Medicinal Products DATE: 17 August 2023 PREPARED BY: EPPA SA/NV Place du Luxembourg 2 1050 Brussels, Belgium EU Transparency Register: 31367501249-92 SOCIO-ECONOMIC ANALYSIS | PFAS | EU REACH SOCIO-ECONOMIC ANALYSIS Of the potential restriction of the per- and polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products PROJECT TITLE: Socio-economic analysis of the potential restriction of the per- and polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products VERSION: 17 August 2023 PREPARED FOR: European Federation of Pharmaceutical Industries and Associations (EFPIA) PERFORMED BY: EPPA (www.eppa.com) CITATION: EPPA, `Socio-economic analysis of the potential restriction of the per- and polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products', Report for EFPIA, July 2023 DISCLAIMER: The views expressed in this report are, unless otherwise stated, those of the authors and do not necessarily represent any official view of EFPIA and/or any other organization mentioned in this report. 2 CONTENTS SOCIO-ECONOMIC ANALYSIS | PFAS | EU REACH CONTENTS......................................................................................................................... 3 ABBREVIATIONS ................................................................................................................ 5 DEFINITIONS ..................................................................................................................... 7 1.

A scientific driven approach, using the current regulatory framework would lead to a future where the use of safer, better-performing chemicals will fortify the European economy and advance progress toward important policy priorities, without undermining health and wellbeing.

Internal Use Only Our Values Our Businesses Titanium Technologies Thermal & Specialized Solutions Advanced Performance Materials Chemical Solutions Market Leader Chemours is a global leader in the safe production and manufacture of performance chemicals, combining leading products, applications expertise, and market-shaping chemistry Market Leader in titanium dioxide (TiO2) production Market Leader in manufacturing of thermal management and specialized solutions Market Leader in manufacturing of advanced performance materials Our Global Reach 58 Manufacturing and laboratory sites 130 Countries where we serve customers 6.4K Employees worldwide Chemours in Europe Manufacturing, Technology and Offices Antwerp (Kallo), Belgium Mechelen, Belgium Dordrecht, the Netherlands Villers-Saint-Paul (Oise), France Geneva (Meyrin), Switzerland Gijon, Spain (O) Neu Isenburg, Germany (O) Gijon Spain Antwerp, Belgium Dordrecht Netherlands Mechelen, Belgium Neu Isenburg Germany Oise France Geneva Switzerland Our manufacturing plant in Dordrecht produces fluoropolymers which are then used as a raw material for our coatings production in Mechelen.

A generally applicable definition is lacking, and this leads to great uncertainty in dealing with PFAS: A central question in the scientific discussion is whether PFAS are a class of materials to which uniform regulatory criteria can be applied.